Favilavir’s Covid-19 Effectiveness Boosts Hisun Pharma, Fujifilm Stock to Limit

Life Science

(Niraparib) for First-Line Maintenance Treatment of Ovarian Cancer in China by the NMPA

Life Science

China’s CanSino pushes coronavirus vaccine into clinical testing as Moderna kicks off trial

Life Science

Healthcare Roundup – AbbVie and Allergan ink agreement, Qiagen to ramp up production of RNA extraction kits for coronavirus tests

Life Science

China biotech InnoCare raises $288 million in Hong Kong IPO: sources

Life Science

InxMed Announces Dosing of First Patient in a Phase Ib Trial of IN10018 as Monotherapy and Combination Therapy in Patients with Uveal Melanoma and NRAS mutant Metastatic Melanoma in the United States

Life Science

Healthcare Roundup – BioELife expands COVID-19 prevention product line, CytoDyn advancing mid-stage study of PRO 140 for COVID-19

Life Science

First Patient Dosed in Moderna’s COVID-19 Vaccine Trial

Life Science

Sanofi and Regeneron begin global Kevzara® (sarilumab) clinical trial program in patients with severe COVID-19

Life Science

BioNTech and Fosun to Develop mRNA Vaccine for COVID-19

Life Science

Healthcare Roundup – President Trump declares national emergency over coronavirus, Gilead up 6% premarket on encouraging action of remdesivir in COVID-19

Life Science

Pfizer tells all US salespeople they must work remotely

Life Science

Healthcare Roundup –Predictive Oncology up 50%，Neogen ramps up production of disinfectants to fight COVID-19

Life Science

Harbour BioMed Secures $85 Million in Financing Round to Support Clinical-Stage Compounds

Life Science

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) + Yervoy® (ipilimumab) for Patients with Hepatocellular Carcinoma (HCC) Previously Treated with Sorafenib

Life Science